Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings

Journal of Clinical Microbiology

Volumn 49, Issue 12, 2011, Pages 4077-4082

  Ziemniak, Carrie ^a   Mengistu, Yohannes ^b   Ruff, Andrea ^c   Chen, Ya Hui ^a   Khaki, Leila ^a   Bedri, Abubaker ^b   Simen, Birgitte B ^d   Palumbo, Paul ^e   Eshleman, Susan H ^a   Persaud, Deborah ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d 454 Life Sciences A Roche Company   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE;

AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ARTICLE; ASSAY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRIED BLOOD SPOT SAMPLE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN HOUSE ASSAY; INTERMETHOD COMPARISON; MUTATION; PHYLOGENY; PRIORITY JOURNAL; VALIDITY; VIRUS LOAD;

AFRICA SOUTH OF THE SAHARA; ANTI-RETROVIRAL AGENTS; BLOOD; CHILD; CHILD, PRESCHOOL; DESICCATION; DEVELOPING COUNTRIES; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; INFANT; SPECIMEN HANDLING;

EID: 82455174874     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01004-11     Document Type: Article

References (17)

1. Bedri, A., et al. 2008. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 372:300-313.
2. Bertagnolio, S., N. T. Parkin, M. Jordan, J. Brooks, and J. G. Garcia-Lerma. 2010. Dried blood spots for HIV-1 drug resistance and viral load testing: a review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS Rev. 12:195-208.
3. Bertagnolio, S., et al. 2007. HIV-1 drug resistance surveillance using dried whole blood spots. Antivir. Ther. 12:107-113. (Pubitemid 46340432)
4. Buckton, A. J. 2008. New methods for the surveillance of HIV drug resistance in the resource poor world. Curr. Opin. Infect. Dis. 21:653-658.
5. Cassol, S. A., et al. 1996. Dried blood spots collected on filter paper: an international resource for the diagnosis and genetic characterization of human immunodeficiency virus type-1. Mem. Inst. Oswaldo Cruz 91:351-358.
6. Fiscus, S. A., et al. 2006. HIV-1 viral load assays for resource-limited settings. PLoS Med. 3:e417.
7. Hamers, R. L., P. W. Smit, W. Stevens, R. Schuurman, and T. F. Rinke de Wit. 2009. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir. Ther. 14:619-629.
8. Johannessen, A., M. Troseid, and A. Calmy. 2009. Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings. J. Antimicrob. Chemother. 64:1126-1129.
9. McNulty, A., et al. 2007. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J. Clin. Microbiol. 45:517-521.
10. Moorthy, A., et al. 2011. Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children. Clin. Infect. Dis. 52:514-521.
11. Palumbo, P., et al. 2010. Antiretroviral treatment for children with peripartum nevirapine exposure. N. Engl. J. Med. 363:1510-1520.
12. Persaud, D., et al. 2011. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to child HIV-transmission. AIDS Res. Hum. Retroviruses 27:823-829.
13. Simen, B. B., et al. 2009. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J. Infect. Dis. 199:693-701.
14. World Health Organization. 2010. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. World Health Organization, Geneva, Switzerland.
15. World Health Organization. 2010. HIV drug resistance early warning indicators. World Health Organization, Geneva, Switzerland.
16. World Health Organization. 2010. WHO manual for HIV drug resistance testing using dried blood spot specimens. World Health Organization, Geneva, Switzerland.
17. Ziemniak, C., A. George-Agwu, W. J. Moss, S. C. Ray, and D. Persaud. 2006. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J. Virol. Methods 136:238-247. (Pubitemid 44051599)